Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of warfarin pharmacogenetic algorithms in clinical practice.
Marin-Leblanc M, Perreault S, Bahroun I, Lapointe M, Mongrain I, Provost S, Turgeon J, Talajic M, Brugada R, Phillips M, Tardif JC, Dubé MP. Marin-Leblanc M, et al. Among authors: talajic m. Pharmacogenomics. 2012 Jan;13(1):21-9. doi: 10.2217/pgs.11.120. Pharmacogenomics. 2012. PMID: 22176621
Atrioventricular interval optimization and exercise tolerance.
Khairy P, Talajic M, Dominguez M, Tardif JC, Juneau M, Lavoie L, Roy D, Dubuc M. Khairy P, et al. Among authors: talajic m. Pacing Clin Electrophysiol. 2001 Oct;24(10):1534-40. doi: 10.1046/j.1460-9592.2001.01534.x. Pacing Clin Electrophysiol. 2001. PMID: 11707048 Clinical Trial.
Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).
Palardy M, Ducharme A, Nattel S, Tardif JC, White M, Racine N, Tétreault K, Dabouz F, Talajic M, Roy D; CTAF Investigators. Palardy M, et al. Among authors: talajic m. Can J Cardiol. 2008 Sep;24(9):709-13. doi: 10.1016/s0828-282x(08)70670-6. Can J Cardiol. 2008. PMID: 18787722 Free PMC article. Clinical Trial.
Increase in sudden death from coronary artery disease in young adults.
Arzamendi D, Benito B, Tizon-Marcos H, Flores J, Tanguay JF, Ly H, Doucet S, Leduc L, Leung TK, Campuzano O, Iglesias A, Talajic M, Brugada R. Arzamendi D, et al. Among authors: talajic m. Am Heart J. 2011 Mar;161(3):574-80. doi: 10.1016/j.ahj.2010.10.040. Am Heart J. 2011. PMID: 21392614
Cardiac remodeling with rhythm versus rate control strategies for atrial fibrillation in patients with heart failure: insights from the AF-CHF echocardiographic sub-study.
Henrard V, Ducharme A, Khairy P, Gisbert A, Roy D, Levesque S, Talajic M, Thibault B, Racine N, White M, Guerra PG, Tardif JC; AF-CHF investigators. Henrard V, et al. Among authors: talajic m. Int J Cardiol. 2013 May 25;165(3):430-6. doi: 10.1016/j.ijcard.2011.08.077. Epub 2011 Sep 13. Int J Cardiol. 2013. PMID: 21917326 Clinical Trial.
Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
O'Meara E, Khairy P, Blanchet MC, de Denus S, Pedersen OD, Levesque S, Talajic M, Ducharme A, White M, Racine N, Rouleau JL, Tardif JC, Roy D; AF-CHF investigators. O'Meara E, et al. Among authors: talajic m. Circ Heart Fail. 2012 Sep 1;5(5):586-93. doi: 10.1161/CIRCHEARTFAILURE.111.965160. Epub 2012 Jul 12. Circ Heart Fail. 2012. PMID: 22798522 Clinical Trial.
315 results